Global Government Tenders

Most trusted source for Tendering Opportunities and Business Intelligence since 2002

Czech Republic pharmaceuticals medical tenders

Get access to latest Czech Republic pharmaceuticals medical tenders and government contracts. Find business opportunities for Czech Republic pharmaceuticals tenders, Czech Republic medical tenders, Czech Republic pharma tenders, Czech Republic Vaccine tenders, Czech Republic vitamins tenders, Czech Republic medicine tenders, pharmaceutical chemicals tenders, Czech Republic drugs tenders, Czech Republic antibiotics tenders, pharmaceutical consumables tenders, Czech Republic medical instrument tenders.

Summary:
Hematology Line
Country:
Czech Republic
Estimated Cost:
EUR 24000000
Notice Type:
Tender Notice
Deadline:
21 Jan 2025
Posting Date:
17 Dec 2024
 
 
 
Summary:
Medicinal Products With The Active Ingredient Larotrectinib Sulfate Ii
Country:
Czech Republic
 
Notice Type:
Tender Notice
Deadline:
16 Jan 2025
Posting Date:
17 Dec 2024
 
 
 
Summary:
Supplies Of Medicinal Products With The Active Ingredient Propofol
Country:
Czech Republic
Estimated Cost:
EUR 5226000
Notice Type:
Tender Notice
Deadline:
20 Jan 2025
Posting Date:
17 Dec 2024
 
 
 
Summary:
Purchase Of Pepsin 1:10,000 Nf 1 Kg.
Country:
Czech Republic
 
Notice Type:
Tender Notice
Deadline:
10 Jan 2025
Posting Date:
14 Dec 2024
 
 
 
Summary:
Drug Supplies – Rituximab - Truxima 2024
Country:
Czech Republic
 
Notice Type:
Tender Notice
Deadline:
15 Jan 2025
Posting Date:
14 Dec 2024
 
 
 
Summary:
Drug Deliveries – Olumiant 2024
Country:
Czech Republic
 
Notice Type:
Tender Notice
Deadline:
15 Jan 2025
Posting Date:
14 Dec 2024
 
 
 
Summary:
Drug Deliveries – Bosentan - Stayveer 2024
Country:
Czech Republic
 
Notice Type:
Tender Notice
Deadline:
15 Jan 2025
Posting Date:
14 Dec 2024
 
 
 
Summary:
Drug Supplies – Rituximab - Truxima 2024
Country:
Czech Republic
 
Notice Type:
Tender Notice
Deadline:
15 Jan 2025
Posting Date:
13 Dec 2024
 
 
 
Summary:
Lp Containing Brentuximab Vedotin 2024
Country:
Czech Republic
 
Notice Type:
Tender Notice
Deadline:
16 Jan 2025
Posting Date:
13 Dec 2024
 
 
 
Summary:
Medicinal Product With The Active Ingredient Adalimumab
Country:
Czech Republic
Estimated Cost:
EUR 18587606
Notice Type:
Tender Notice
Deadline:
13 Jan 2025
Posting Date:
13 Dec 2024